Avinger Shares Rise 9% After 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
27 April 2023 - 12:25AM
Dow Jones News
By Chris Wack
Avinger Inc. shares were up 9% at 61 cents after the company
said it has received 510(k) clearance from the U.S. Food & Drug
Administration for Tigereye ST, its next-generation image-guided
chronic total occlusion crossing system.
The commercial-stage medical device company said its Tigereye ST
expands and advances its proprietary image-guided chronic total
occlusion product line with new features and benefits.
The new Tigereye ST incorporates design upgrades to the tip
configuration and catheter shaft to increase crossing power and
procedural success in challenging lesions, as well as design
enhancements for ease of image interpretation during the
procedure.
Avinger will initiate a limited launch of Tigereye ST in the
current quarter with plans to expand to full commercial
availability in the U.S. in the third quarter of 2023.
The company also said Wednesday that its stock price was no
longer in compliance with Nasdaq's minimum bid price rule, and it
has until Oct. 23 to regain compliance.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
April 26, 2023 10:10 ET (14:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Avangard Capital (GM) (USOTC:AVGC)
Historical Stock Chart
From Apr 2024 to May 2024
Avangard Capital (GM) (USOTC:AVGC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Avangard Capital Group Inc (GM) (OTCMarkets): 0 recent articles
More Avangard Capital Group Inc (GM) News Articles